CECELIA HOWARD: Open Payments
NPI 1518378843 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 98 payments from 10 companies in 2025. Trend: 2023 $770 · 2024 $854 · 2025 $1,440
Food & beverage: $1,440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $317 |
| Janssen Biotech, Inc. | 15 | $299 |
| Phathom Pharmaceuticals, Inc. | 28 | $205 |
| QOL Medical, LLC | 7 | $196 |
| Madrigal Pharmaceuticals | 15 | $177 |
| GENZYME CORPORATION | 5 | $109 |
| Ardelyx, Inc. | 3 | $69 |
| Lilly USA, LLC | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: TREMFYA, VOQUEZNA, Sucraid, REZDIFFRA, MAVYRET, RINVOQ, DUPIXENT, IBSRELA.
Industry payments across KY — which companies pay providers there.
